These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7942884)

  • 1. AAP advises on timing of measles vaccination after immune globulin use.
    Am J Hosp Pharm; 1994 Jul; 51(13):1600, 1603. PubMed ID: 7942884
    [No Abstract]   [Full Text] [Related]  

  • 2. Measles vaccination in HIV-infected children.
    Rose VL; Preboth M
    Am Fam Physician; 1999 Nov; 60(7):2179. PubMed ID: 10569516
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age.
    Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cell-mediated response after measles vaccination].
    Pala S; Crimaldi G; Consolini R; Macchia P
    Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
    Liu BY; Feng ZX; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
    de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
    Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study.
    Dhiman N; Ovsyannikova IG; Oberg AL; Grill DE; Jacobson RM; Poland GA
    Hum Immunol; 2005 Nov; 66(11):1125-36. PubMed ID: 16571413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
    Leuridan E; Van Damme P
    Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A seroconversion study of the measles component of the MMR vaccine in adolescents of the town of Sabrosa].
    Gonçalves G; Tavares F; de Andrade HR
    Acta Med Port; 1998 Dec; 11(12):1079-84. PubMed ID: 10192981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiological efficacy of mass vaccination against measles among the troops].
    Sibilev VI; Shevtsova VA; Tiasto EA
    Voen Med Zh; 1994 Feb; (2):50-1, 80. PubMed ID: 8165796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.